Benitec Biopharma Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Benitec Biopharma stock have an average target of 23, with a low estimate of 16 and a high estimate of 30. The average target predicts an increase of 164.37% from the current stock price of 8.70.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$16	$23	$30	$30
Change	+83.91%	+164.37%	+244.83%	+244.83%

Analyst Ratings

The average analyst rating for BNTC stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '24	Feb '24	Mar '24	Apr '24	May '24	Jun '24
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Initiates $30	Buy	Initiates	$30	+244.83%	Jun 13, 2024
Silvan Tuerkcan JMP Securities	JMP Securities	Buy Maintains $10 → $16	Buy	Maintains	$10 → $16	+83.91%	Apr 22, 2024
Silvan Tuerkcan JMP Securities	JMP Securities	Buy Maintains $8 → $10	Buy	Maintains	$8 → $10	+14.94%	Feb 15, 2024
Silvan Tuerkcan JMP Securities	JMP Securities	Buy Maintains $6 → $8	Buy	Maintains	$6 → $8	-8.05%	Jan 24, 2024
Silvan Tuerkcan JMP Securities	JMP Securities	Buy Maintains $4 → $6	Buy	Maintains	$4 → $6	-31.03%	Sep 26, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 75.00K

Revenue Next Year

n/a

EPS This Year

-5.21

from -0.14

EPS Next Year

-1.93

from -5.21

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027
Revenue	12.20M	102.00K	59.00K	73.00K	75.00K	-	-	-	66.72M
Revenue Growth	291.99%	-99.16%	-42.16%	23.73%	2.74%	-	-	-	-
EPS	0.52	-1.38	-0.55	-0.38	-0.14	-5.21	-1.93	-	-
EPS Growth	-	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	3	3

Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027
High	n/a	n/a	n/a	68.7M
Avg	n/a	n/a	n/a	66.7M
Low	n/a	n/a	n/a	64.1M

Revenue Growth

Revenue Growth	2024	2025	2026	2027
High	-	-	-	-
Avg	-	-	-	-
Low	-	-	-	-

EPS Forecast

EPS	2024	2025
High	-2.67	-0.94
Avg	-5.21	-1.93
Low	-7.52	-2.82

EPS Growth

EPS Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.